DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity

Immunology Letters

Volumn 114, Issue 2, 2007, Pages 86-93

  Lin, Cheng Tao ^a   Tsai, Ya Chea ^b   He, Liangmei ^b   Yeh, Chun Nan ^a   Chang, Ting Chang ^a   Soong, Yung Kuei ^a   Monie, Archana ^b   Hung, Chien Fu ^b   Lai, Chyong Huey ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

DNA vaccine; E7; HPV; IL 2

Indexed keywords

ANTIGEN; DNA VACCINE; INTERLEUKIN 2; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CD8+ T LYMPHOCYTE; DRUG POTENCY; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNITY; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CANCER VACCINES; HUMAN PAPILLOMAVIRUS 16; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS VACCINES; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 36549019001     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.09.008     Document Type: Article

References (20)

1. Boyd D., Hung C.F., and Wu T.C. DNA vaccines for cancer. IDrugs 6 (2003) 1155-1164
2. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18 (2000) 927-974
3. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
4. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo Jr. L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2 (1996) 1122-1128
5. Porgador A., Irvine K.R., Iwasaki A., Barber B.H., Restifo N.P., and Germain R.N. Predominant role for directly transfected dendritic cells in antigen presentation to CD8 + T cells after gene gun immunization. J Exp Med 188 (1998) 1075-1082
6. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6 (2006) 595-601
7. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., and Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71 (1997) 169-178
8. Lin C.C., Chou C.W., Shiau A.L., Tu C.F., Ko T.M., Chen Y.L., et al. Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu. Molec Therapy 10 (2004) 290-301
9. Li W.R., Niu B., Wang J.W., Feng Z.J., and Wang D.X. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D. Acta Virol 50 (2006) 251-256
10. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
11. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat Rev Cancer 6 (2006) 753-763
12. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
13. Lin K.Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 56 (1996) 21-26
14. He Z., Wlazlo A.P., Kowalczyk D.W., Cheng J., Xiang Z.Q., Giles-Davis W., et al. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology 270 (2000) 146-161
15. Hung C.F., Hsu K.F., Cheng W.F., Chai C.Y., He L., Ling M., et al. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res 61 (2001) 1080-1088
16. Ji H., Wang T.-L., Chen C.-H., Hung C.-F., Pai S., Lin K.-Y., et al. Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7-expressing tumors. Human Gene Therapy 10 (1999) 2727-2740
17. Bloom M.B., Perry-Lalley D., Robbins P.F., Li Y., el-Gamil M., Rosenberg S.A., et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med 185 (1997) 453-459
18. Chen C.H., Wang T.L., Hung C.F., Yang Y., Young R.A., Pardoll D.M., et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 60 (2000) 1035-1042
19. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 (2001) 7888-7898
20. Trimble C., Lin C.T., Hung C.F., Pai S., Juang J., He L., et al. Comparison of the CD8 + T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21 (2003) 4036-4042